Sequence Similarity Clusters for the Entities in PDB 5NHW

Entity #1 | Chains: H
anti-human ActRII Bimagrumab Fab heavy-chain protein, length: 236 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 1 1 73567
95 % 1 1 61213
90 % 8 58 663
70 % 252 2965 1
50 % 270 3117 1
40 % 270 3117 1
30 % 531 6228 1
Entity #2 | Chains: L
anti-human ActRII Bimagrumab Fab light-chain protein, length: 216 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 1 1 73569
95 % 1 1 61214
90 % 5 92 265
70 % 49 613 7
50 % 255 3067 2
40 % 255 3067 2
30 % 532 6228 1

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 4NZU 1 L 13PL heavy chain Fab 9606
2 4NZU 2 H 13PL light chain Fab 9606
3 1MJU 1 L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090
4 1MJU 2 H IMMUNOGLOBULIN MS6-12 Fab fragment, HEAVY CHAIN 10090
5 4TRP 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
6 4TRP 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
7 1MEX 1 L Fab 29G12 light chain 10090
8 1MEX 2 H Fab 29G12 heavy chain 10090
9 3D9A 2 L Light Chain of HyHel10 Antibody Fragment (Fab) 10090
10 3D9A 3 H Heavy Chain of HyHel10 Antibody Fragment (Fab) 10090
11 4BUH 1 A, B CLONE M0418 SCFV 9606
12 3TV3 1 L PGT128 light chain, Ig lambda-2 chain C regions PGT128 light chain 9606
13 3TV3 2 H PGT128 heavy chain, Ig gamma-1 chain C region PGT128 heavy chain 9606
14 1NCW 1 L IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, light chain 10090
15 1NCW 2 H IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, heavy chain 10090
16 5YD4 1 A, C, E, G scFv 4B08 10090
17 5YD3 1 A, C, E, G scFv 4B08 10090
18 5UD9 1 H Fab heavy chain 9606
19 5UD9 2 L Light chain 9606
20 4P48 1 A Antibody scFv 180 9031
21 6DDM 1 A Anti-MICA Fab fragment light chain clone 1D5 10090
22 6DDM 3 B Anti-MICA Fab fragment heavy chain clone 1D5 10090
23 5TY6 1 H VRC 315 13-1b02 Fab Heavy chain 9606
24 5TY6 2 L VRC 315 13-1b02 Fab Light chain 9606
25 2XZC 1 H FAB A.17 HEAVY CHAIN 9606
26 2XZC 2 L FAB A.17 LIGHT CHAIN 9606
27 2XKN 1 A, C ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT LIGHT CHAIN (IGG1), RESIDUES 1-223 10090
28 2XKN 2 B, D ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT HEAVY CHAIN (IGG1), RESIDUES 1-216 10090
29 6MEE 1 A, C antibody HEPC74 Heavy Chain 9606
30 6MEE 2 B, D antibody HEPC74 Light Chain 9606
31 6BJZ 1 H 5c8 Fab Heavy chain 9606
32 6BJZ 2 L 5c8 Fab Light chain 9606
33 6O3D 1 L PGZL1 FAB LIGHT CHAIN 9606
34 6O3D 2 H PGZL1 FAB HEAVY CHAIN 9606
35 5KVG 2 L ZV-67 Antibody Fab Light Chain 10090
36 5KVG 3 H ZV-67 Antibody Fab Heavy Chain 10090
37 5WCA 1 H VRC315 27-1C08 Fab Heavy chain 9606
38 5WCA 2 L VRC315 27-1C08 Fab Light chain 9606
39 4XCF 1 L 4E10 Fab light chain 9606
40 4XCF 2 H 4E10 Fab heavy chain 9606
41 5KVF 2 L ZV-64 Antibody Fab Light Chain 10090
42 5KVF 3 H ZV-64 Antibody Fab Heavy Chain 10090
43 1RUP 1 L immunoglobulin igg2a, heavy chain fab 10090
44 1RUP 2 H immunoglobulin igg2a, light chain fab 10090
45 3ESU 1 F Antibody 14b7* light chain and antibody 14b7* heavy chain linked with a synthetic (GGGGS)4 linker 10090
46 1RUK 1 L immunoglobulin igg2a, light chain fab 10090
47 1RUK 2 H immunoglobulin igg2a, heavy chain fab 10090
48 5VXR 1 H MAb24 Variable Heavy Chain,MAb24 Variable Heavy Chain 10090
49 5VXR 2 L MAb24 Variable Light Chain,MAb24 Variable Light Chain 10090
50 5X08 1 H Fab 4E10 Heavy chain 9606
51 5X08 2 L Fab 4E10 Light chain 9606
52 6NB8 1 H S230 antigen-binding (Fab) fragment, heavy chain 9606
53 6NB8 2 L S230 antigen-binding (Fab) fragment, light chain 9606
54 6A76 1 L Light chain of the anti-human Robo1 antibody B5209B Fab 10090
55 6A76 2 H Heavy chain of the anti-human Robo1 antibody B5209B Fab 10090
56 6U1T 1 H antigen-binding (Fab) fragment, heavy chain 10090
57 6U1T 2 L antigen-binding (Fab) fragment, light chain 10090
58 6MEG 1 H antibody HEPC46 Heavy Chain 9606
59 6MEG 2 L antibody HEPC46 Light Chain 9606
60 6O3K 1 L PGZL1.H4K3 light chain 9606
61 6O3K 2 H PGZL1.H4K3 heavy chain 9606
62 4XAW 1 L 4E10 Fab light chain 9606
63 4XAW 2 H 4E10 Fab heavy chain 9606
64 4P49 1 A Antibody scFv B8 9031
65 3N9G 1 H Fab fragment of MAb CR4354, heavy chain 9606
66 3N9G 2 L Fab fragment of MAb CR4354, light chain 9606
67 4TUL 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
68 4TUL 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
69 5UCB 1 H Fab Heavy Chain 9606
70 5UCB 2 L Fab Light Chain 9606
71 2VXV 1 H HUMAN IGG ABT-325 9606
72 2VXV 2 L HUMAN IGG ABT-325 9606
73 6QF9 1 A, B scFv 9606
74 6FRJ 1 H scFv-SM3 Although this structure is a ScFv, please follow the same numbering as shown in PDB entry 5OWP. 10090
75 4GXV 1 H, I Antibody 1F1, heavy chain 9606
76 4GXV 2 L, M Antibody 1F1, light chain 9606
77 2VXT 1 H MURINE IGG 125-2H 10090
78 2VXT 3 L MURINE IGG 125-2H 10090
79 6CR1 1 L Light chain of adalimumab EFab (VL-IgE CH2) 9606
80 6CR1 2 H Heavy chain of adalimumab EFab (VH-IgE CH2) 9606
81 1RUM 1 L immunoglobulin igg2a, light chain fab 10090
82 1RUM 2 H immunoglobulin igg2a, heavy chain fab 10090
83 2XZA 1 H FAB A.17 HEAVY CHAIN 9606
84 2XZA 2 L FAB A.17 LIGHT CHAIN 9606
85 2W60 1 A ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
86 2W60 2 B ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
87 5W24 1 L 5C4 Fab Light Chain 10090
88 5W24 2 H 5C4 Fab Heavy Chain 10090
89 4HPY 1 H CH59 Fab heavy chain 9606
90 4HPY 2 L CH59 Fab light chain 9606
91 3T65 1 B S25-2 FAB (IGG1K) heavy chain 10090
92 3T65 2 A S25-2 FAB (IGG1K) light chain 10090
93 5C6W 1 H, J Protein IGHV1-69-2,Ig lambda chain V-II region NIG-84 9606
94 4JG1 1 L Fab light chain 9606
95 4JG1 2 H Fab heavy chain 9606
96 6E65 1 L TB31F Fab light chain 9606
97 6E65 2 H TB31F Fab heavy chain 9606
98 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606
99 3M8O 2 H IMMUNOGLOBULIN A1 HEAVY CHAIN Fab fragment 9606
100 5VF2 1 A scFv 2D10 10090
101 5I8C 1 A VRC34.01 Fab heavy chain 9606
102 5I8C 2 B VRC34.01 Fab light chain 9606
103 4O5L 1 L Fab F045-092 light chain 9606
104 4O5L 2 H Fab F045-092 heavy chain 9606
105 5MYX 1 A, C Fab c#24 light chain 10090
106 5MYX 2 B, D Fab c#24 heavy chain Pyroglutamate residue 1 (PCA) results from post-translational modification of original residue glutamine 1. 10090
107 3IFL 1 L 12A11 FAB antibody light chain 10090
108 3IFL 2 H 12A11 FAB antibody heavy chain 10090
109 5WK2 1 L M116 LIGHT CHAIN 9606
110 5WK2 2 H M116 HEAVY CHAIN FD 9606
111 3PP4 1 H GA101 Fab heavy chain 10090
112 3PP4 2 L GA101 Fab light chain 10090
113 3KDM 1 A, L Immunoglobulin light chain 9606
114 3KDM 2 B, H Immunoglobulin heavy chain 9606
115 5NIV 1 A Light chain of 5D3 Fab 10090
116 5NIV 2 B Heavy chain of 5D3 Fab 10090
117 5N4J 1 L LIGHT CHAIN 9606
118 5N4J 2 H HEAVY CHAIN the sequence provided include the cleavable tag 9606
119 2AJU 1 L ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
120 2AJU 2 H ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
121 2AJV 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
122 2AJV 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
123 5X4G 1 A 6H8 Fab heavy chain 10090
124 5X4G 2 B 6H8 Fab light chain 10090
125 3SY0 1 A S25-2 FAB (IGG1K) light chain 10090
126 3SY0 2 B S25-2 FAB (IGG1K) heavy chain 10090
127 4PTU 1 A Antibody pn132p2C05, light chain 9606
128 4PTU 2 B Antibody pn132p2C05, heavy chain 9606
129 4TPR 1 L If kappa light chain 10090
130 4TPR 2 H Fab heavy chain 10090
131 6HGU 1 A, H anti-APP-tag Fab heavy-chain 10090
132 6HGU 2 B, L anti-APP-tag Fab light-chain anti-APP-tag Fab heavy-chain 10090
133 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
134 4HS6 3 B, H MRCT10.v362 Fab heavy chain 9606
135 3IFN 1 H 12A11 FAB antibody heavy chain 10090
136 3IFN 2 L 12A11 FAB antibody light chain 10090
137 5U3P 1 H DH511.4 Fab Heavy Chain 9606
138 5U3P 2 L DH511.4 Fab Light Chain 9606
139 6BLA 1 H AMM01 Fab Heavy chain 9606
140 6BLA 2 L AMM01 Fab Light chain 9606
141 4TOY 1 H 35O22 Fab Heavy chain 9606
142 4TOY 2 L 35O22 Fab Light chain 9606
143 4TUO 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
144 4TUO 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
145 3NPS 2 B S4 FAB HEAVY CHAIN 9606
146 3NPS 3 C S4 FAB LIGHT CHAIN 9606
147 5I4F 1 A scFv 2D10 10090
148 1RUR 1 L immunoglobulin 13G5, light chain fab 10090
149 1RUR 2 H immunoglobulin 13G5, heavy chain fab 10090
150 5ADO 1 H FAB A.17 HEAVY CHAIN 9606
151 5ADO 2 L FAB A.17 LIGHT CHAIN 9606
152 5WN9 1 H scFv 2D10 9606
153 4XC3 1 L 4E10 Fab light chain 9606
154 4XC3 2 H 4E10 Fab heavy chain 9606
155 1X9Q 1 A 4m5.3 anti-fluorescein single chain antibody fragment antibody binding fragment 9606
156 4M5Y 1 H, I Fab 5J8 heavy chain 9606
157 4M5Y 2 L, M Fab 5J8 light chain 9606
158 4TQE 1 L If kappa light chain 10090
159 4TQE 2 H Fab heavy chain 10090
160 5YY4 1 A scFv 4B08 10090
161 4ISV 1 A 1C2 FAB LIGHT CHAIN 10090
162 4ISV 2 B 1C2 FAB HEAVY CHAIN 10090
163 4XC1 1 L 4E10 FAB LIGHT CHAIN 9606
164 4XC1 2 H 4E10 FAB HEAVY CHAIN 9606
165 5VSI 1 H CH1/Ckappa Fab heavy chain 9606
166 5VSI 2 L CH1/Ckappa Fab light chain 9606
167 5ODB 1 A D10 Fab fragment - heavy chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
168 5ODB 2 B D10 Fab fragment - light chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
169 4CMH 2 B HEAVY CHAIN OF SAR650984-FAB FRAGMENT 10090
170 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090
171 5JXA 1 H VRC03 Heavy chain 9606
172 5JXA 2 L VRC03 Light chain 9606
173 3QHZ 1 H, I Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
174 3QHZ 2 L, M Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
175 6QCU 1 L Light chain 9606
176 6QCU 2 H Heavy chain 9606
177 3UJI 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
178 3UJI 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
179 3NTC 1 L Fab light chain 10090
180 3NTC 2 H Fab heavy chain 10090
181 4YNY 1 A, C Heavy chain of antigen binding fragment, Fab 10116
182 4YNY 2 B, D Light chain of antigen binding fragment, Fab 10116
183 4TUK 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
184 4TUK 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
185 4YO0 1 A, C Heavy chain of antigen binding fragment, Fab 10116
186 4YO0 2 B, D Light chain of antigen binding fragment, Fab 10116
187 6PZG 1 L NA-80 Fab light chain 9606
188 6PZG 2 H NA-80 Fab heavy chain 9606
189 6AZM 1 A, C 580 germline antibody, light chain Fragment: Fab 9606
190 6AZM 2 B, D 580 germline antibody, heavy chain Fragment: Fab 9606
191 6BE3 1 H Fab (F598) Heavy Chain 9606
192 6BE3 2 L Fab (F598) Light Chain 9606
193 4NWU 1 H APE1551 Ab Fab heavy chain 9606
194 4NWU 2 L APE1551 Ab Fab light chain 9606
195 3HC4 1 H IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
196 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
197 5VZR 1 A, H G4 antibody heavy chain Fab fragment 10090
198 5VZR 2 B, L G4 antibody light chain Fab fragment 10090
199 2W9D 1 H ICSM 18-ANTI-PRP THERAPEUTIC FAB HEAVY CHAIN 10090
200 2W9D 2 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090
201 5EWI 1 H VRC38.01 Heavy Chain 9606
202 5EWI 2 L VRC38.01 Light Chain 9606
203 6SVL 1 A, D, G, H, K, O Fab_heavy_chain 9606
204 6SVL 2 B, E, I, L, M, P Fab_light_chain 9606
205 5E2W 1 L AT8 LIGHT CHAIN 10090
206 5E2W 2 H AT8 HEAVY CHAIN 10090
207 5MYK 1 A Fab c#17 light chain 10090
208 5MYK 2 B Fab c#17 heavy chain 10090
209 4NZR 1 H PGT135 heavy chain Fab 9606
210 4NZR 2 L PGT135 light chain Fab 9606
211 5MYO 1 A, C Fab c#6 light chain 10090
212 5MYO 2 B, D Fab c#6 heavy chain 10090
213 4HBC 1 H Antigen Binding Fragment, Immunoglobulin IgG - Heavy Chain 9986
214 4HBC 2 L Antigen Binding Fragment, Immunoglobulin IgG - Light Chain 9986
215 4AEH 1 H FAB ANTIBODY, HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-231 10090
216 4AEH 2 L FAB ANTIBODY, LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-214 10090
217 5UEL 1 H 354NC102 Fab Heavy Chain 9606
218 5UEL 2 L 354NC102 Fab Light Chain 9606
219 3UZQ 1 A anti-dengue Mab 4E11 Single chain variable fragment 10090
220 2V17 2 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
221 2V17 3 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
222 4J6R 2 H HEAVY CHAIN OF ANTIBODY VRC23 9606
223 4J6R 3 L LIGHT CHAIN OF ANTIBODY VRC23 9606
224 5E2V 1 L AT8 LIGHT CHAIN 10090
225 5E2V 2 H AT8 HEAVY CHAIN 10090
226 5SY8 1 H 10E8 FAB HEAVY CHAIN 9606
227 5SY8 2 L 10E8 FAB LIGHT CHAIN 9606
228 5OCK 1 L Human ACPA E4 Fab fragment - Light chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
229 5OCK 2 H Human ACPA E4 Fab fragment - Heavy chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
230 5DD1 1 H ANTI-HIV ANTIBODY DH570 FAB HEAVY CHAIN 9544
231 5DD1 2 L ANTI-HIV ANTIBODY DH570 FAB LIGHT CHAIN 9544
232 5JUE 1 L light chain of UIC2 Fab 10090
233 5JUE 2 H heavy chain of UIC2 Fab 10090
234 5CIN 1 H FAB 4E10 HEAVY CHAIN 9606
235 5CIN 2 L FAB 4E10 LIGHT CHAIN 9606
236 5A2J 1 H SCFV-SM3 CONTAINS BOTH H AND L CHAINS OF SCFV-SM3, CONNECTEDBY A LINKER. CHAIN L RESIDUES ARE NUMBERED FROM 1000. RESIDUES 6-115,20-129 10090
237 5JR1 1 H 10E8 heavy chain 9606
238 5JR1 2 L 10E8 mature light chain 9606
239 6CA7 1 L PCT64_13C light chain 9606
240 6CA7 2 H PCT64_13C heavy chain 9606
241 5VF6 1 A single chain variable fragment 9031
242 3CFB 1 A, L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
243 3CFB 2 B, H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
244 3WII 1 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
245 3WII 2 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
246 6K4Z 1 A, B scFv of C6 The fusion protein of expression tags (residues -2-0), the light chain (residues 1-108), linker GGGGSGGGGSGGGGS (residues 501-515), and the heavy chain (residues 1001-1113) 10090
247 6MVL 2 H Antibody Fab fragment heavy chain 9606
248 6MVL 3 L Antibody Fab fragment light chain 9606
249 5OB5 2 H fAb Heavy chain 9606
250 5OB5 3 L fAb Light chain 9606
251 3BKJ 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
252 3BKJ 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
253 5I66 1 A 8B6 antibody, heavy chain 10090
254 5I66 2 B 8B6 antibody, light chain 10090
255 6QBC 1 H Anti-Mcl1 Fab Heavy Chain 9606
256 6QBC 2 L Anti-Mcl1 Fab Light Chain 9606
257 4JAM 1 A, H ANTIGEN BINDING FRAGMENT OF HEAVY CHAIN of CH103 9606
258 4JAM 2 B, L ANTIGEN BINDING FRAGMENT OF LIGHT CHAIN of CH103 9606
259 6BZY 1 H 22D11 Heavy Chain 10090
260 6BZY 2 L 22D11 Light Chain 10090
261 3QQ9 1 C, L 101F LIGHT CHAIN 10090
262 3QQ9 2 D, H 101F HEAVY CHAIN 10090
263 5TKK 2 H mouse antibody vFP5.01 heavy chain 10090
264 5TKK 3 L mouse antibody vFP5.01 light chain 10090
265 5FGB 1 A, B Anti-HCV E2 Fab HC84-1 light chain 9606
266 5FGB 2 C, E Anti-HCV E2 Fab HC84-1 heavy chain 9606
267 5W6C 1 H UCA Fab heavy chain 9606
268 5W6C 2 L UCA Fab light chain 9606
269 5I1K 1 L FAB LIGHT CHAIN 9606
270 5I1K 2 H FAB HEAVY CHAIN 9606
271 3OZ9 1 L Fab NC-1 kappa light chain 10090
272 3OZ9 2 H Fab NC-1 IgG2a heavy chain 10090
273 4JDV 1 A, H Fab heavy chain NIH45-46 Germ-line HEAVY CHAIN, IG GAMMA-1 CHAIN 9606
274 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606
275 5V7U 1 L CBTAU-22.1 Fab light chain 9606
276 5V7U 2 H CBTAU-22.1 Fab heavy chain 9606
277 5UEA 1 A, H Fab Heavy Chain 9606
278 5UEA 3 B, L Fab Light Chain 9606
279 4AL8 2 H FAB 2H12 HEAVY CHAIN 9606
280 4AL8 3 L FAB 2H12 LIGHT CHAIN 9606
281 3G5Y 1 A 175 light chain 10090
282 3G5Y 2 B 175 heavy chain 10090
283 5NMV 1 L Fab light chain 10088
284 5NMV 2 H Fab heavy chain 10088
285 4N8C 1 H, I Heavy chain of monoclonal antibody 10090
286 4N8C 2 L, M Light chain of monoclonal antibody 10090
287 5AZ2 1 H anti-human epiregulin antibody 9E5 Fab heavy chain 10090
288 5AZ2 2 L anti-human epiregulin antibody 9E5 Fab light chain 10090
289 4HGW 1 A Antibody Fab fragment, light chain 10090
290 4HGW 2 B Antibody Fab fragment, heavy chain 10090
291 1NLB 1 L antibody 19D9D6 light chain 10090
292 1NLB 2 H antibody 19D9D6 heavy chain 10090
293 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090
294 1C5C 2 H CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 109-230) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-108) IS FROM MURINE SOURCE FAB 10090
295 3VFG 1 L 3F8 Light Chain 10090
296 3VFG 2 H 3F8 Heavy Chain 10090
297 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
298 5TDN 2 B, D anti-HER2 Fab Heavy Chain 9606
299 3QRG 1 L Fab light chain 9606
300 3QRG 2 H Fab heavy chain Fd fragment 9606
301 5M6A 1 A, B, C, D Bence-Jones light chain 9606
302 4LLY 1 A, C mutated Pertuzumab Fab heavy chain 9606
303 4LLY 2 B, D light chain Clambda 9606
304 4EBQ 1 H anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, heavy chain Fab 10090
305 4EBQ 2 L anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, light chain 10090
306 5EZI 1 H Fab c12 heavy chain 9606
307 5EZI 2 L Fab c12 Light chain 9606
308 4K23 1 H anti-uPAR antibody, heavy chain 10090
309 4K23 2 L anti-uPAR antibody, light chain 10090
310 3NCJ 1 L Fab15 Mut8 light chain 9606
311 3NCJ 2 H Fab15 Mut8 heavy chain 9606
312 3UO1 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
313 3UO1 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
314 4M1G 1 L Murine IgG2a A27D7 Light chain Fab domain 10090
315 4M1G 2 H Murine IgG2a A27D7 Heavy chain Fab domain 10090
316 5W05 1 L M59 FAB LIGHT CHAIN 10090
317 5W05 2 H M59 FAB HEAVY CHAIN FD 10090
318 2IPU 1 K, L IgG2a Fab fragment Heavy Chain 10090
319 2IPU 2 G, H IgG2a Fab fragment Light Chain Kappa 10090
320 3HC3 1 H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
321 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
322 4M61 1 A, C Fab A52 light chain 10090
323 4M61 2 B, D Fab A52 heavy chain 10090
324 5YE3 1 B 2A7D9 VH CH1 chain 10090
325 5YE3 2 A 2A7D9 L chain 10090
326 3BKM 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
327 3BKM 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
328 1UM5 1 L Antibody 21H3 L chain 10090
329 1UM5 2 H Antibody 21H3 H chain 10090
330 3QHF 1 H Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
331 3QHF 2 L Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
332 4NWT 1 L APE1531 Ab Fab light chain 9606
333 4NWT 2 H APE1531 Ab Fab heavy chain 9606
334 3WHX 1 A mAb Fab H fragment 10090
335 3WHX 2 B mAb Fab L fragment 10090
336 3NA9 1 L Fab15 light chain 9606
337 3NA9 2 H Fab15 heavy chain 9606
338 3BAE 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
339 3BAE 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
340 6RCO 1 A, C R5.004 heavy chain 9606
341 6RCO 2 B, D R5.004 light chain 9606
342 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
343 1NGZ 2 B Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
344 4LRI 1 A, B MSL-109 Light Chain 9606
345 4LRI 2 C, P MSL-109 Heavy Chain 9606
346 4ZTP 1 L Light chain of Fab fragment of rabbit monoclonal antibody R53 9986
347 4ZTP 2 H Heavy chain of Fab fragment of rabbit monoclonal antibody R53 9986
348 4JN2 1 A, L anti dabigatran Fab 10090
349 4JN2 2 B, H anti dabigatran Fab 10090
350 4XBE 1 L 4E10 FAB LIGHT CHAIN 9606
351 4XBE 2 H 4E10 Fab heavy chain 9606
352 1MJ8 1 L IMMUNOGLOBULIN MS6-126 Fab Fragment, LIGHT CHAIN 10090
353 1MJ8 2 H IMMUNOGLOBULIN MS6-126 Fab Fragment, HEAVY CHAIN 10090
354 6BE2 1 H Fab (F598) Heavy Chain 9606
355 6BE2 2 L Fab (F598) Light Chain 9606
356 4JFZ 1 L Fab light chain 9606
357 4JFZ 2 H Fab heavy chain 9606
358 6ARP 1 A, C Cetuximab mutant light chain,Uncharacterized protein 9606
359 6ARP 2 B, D Cetuximab mutant Fab heavy chain,Immunoglobulin gamma-1 heavy chain 9606
360 3WIF 1 A mAb Fab H fragment 10090
361 3WIF 2 B mAb Fab L fragment 10090
362 5U6A 1 A Light Chain 9606
363 5U6A 2 B Heavy Chain 9606
364 5KVD 2 L ZV-2 Antibody Fab Light Chain 10090
365 5KVD 3 H ZV-2 Antibody Fab Heavy Chain 10090
366 3MBX 1 L X836 LIGHT CHAIN 10090
367 3MBX 2 H X836 HEAVY CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN, FD fragment 10090
368 3TWC 1 L PGT127 light chain, Ig lambda-2 chain C regions 9606
369 3TWC 2 H PGT127 heavy chain, Ig gamma-1 chain C region 9606
370 6APC 1 H Epididymis luminal protein 214 9606
371 6APC 2 L IGL@ protein 9606
372 4HHA 1 A Fab KE5 Fab fragment KE5 9606
373 4HHA 2 B Antibody KE5 AD-2S1 eptiope 9606
374 6FZQ 1 H scFv-1SM3,scFv-1SM3 10090
375 5A2K 1 H IG LAMBDA-1 CHAIN V REGION S43 RESIDUES 6-115,20-129 10090
376 4RGO 2 H 14G8 heavy chain Fab 10090
377 4RGO 3 L 14G8 light chain Fab 10090
378 5N7B 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region S43 Please follow the numbering described in the PDB entry 5A2K 10090
379 5GRY 1 A, G diabody 9606
380 5UEK 2 H Fab 12E Heavy Chain 9606
381 5UEK 3 L Fab 12E Light Chain 9606
382 3NAA 1 L Fab15 Mut5 light chain 9606
383 3NAA 2 H Fab15 Mut5 heavy chain 9606
384 1Q0X 1 L Fab 9B1, light chain 10090
385 1Q0X 2 H Fab 9B1, heavy chain 10090
386 4R90 1 L Anti CD70 Llama glama Fab 27B3 Light chain 9844
387 4R90 2 H Anti CD70 Llama glama Fab 27B3 Heavy chain 9844
388 4XVT 2 H donor 45 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Heavy chain 9606
389 4XVT 3 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Light chain 9606
390 5IK3 1 A, C 1E03 Fab fragment heavy chain 9606
391 5IK3 2 B, D 1E03 Fab fragment light chain 9606
392 5NPH 2 H Heavy chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
393 5NPH 3 L Light chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
394 5XLI 1 a, b FabL 10090
395 5XLI 2 c, d FabH 10090
396 5IHZ 1 A, C, E, H 1E01 Fab fragment heavy chain 9606
397 5IHZ 2 B, D, F, L 1E01 Fab fragment light chain 9606
398 6DC4 1 H Fab AM22 Heavy Chain 9606
399 6DC4 2 L Fab AM22 Light Chain 9606
400 2R1X 1 A Fab, antibody fragment (IgG1k), light chain 10090
401 2R1X 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
402 5U3D 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
403 5U3D 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
404 4WUK 1 H CH65 heavy chain 9606
405 4WUK 2 L CH65 light chain 9606
406 3MLY 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
407 3MLY 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
408 5U3O 1 H DH511.2_K3 Fab Heavy Chain 9606
409 5U3O 2 L DH511.2_K3 Fab Light Chain 9606
410 5JOP 1 D, L Fab 14.22 light chain 10090
411 5JOP 2 E, H Fab14.22 heavy chain 10090
412 4HPO 1 H CH58 Fab heavy chain 9606
413 4HPO 2 L CH58 Fab light chain 9606
414 5UKN 1 H DH522UCA Fab fragment heavy chain 9544
415 5UKN 2 L DH522UCA Fab fragment light chain 9544
416 6BHZ 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
417 6BHZ 2 L, M Trastuzumab Anti-HER2 Fab Light Chain D185A 9606
418 5IT2 1 H heavy chain 9606
419 5IT2 2 L light chain 9606
420 6MY4 1 A, H anti-VEGF-A Fab fragment bH1 heavy chain 9606
421 6MY4 2 B, L anti-VEGF-A Fab fragment bH1 light chain 9606
422 4POZ 1 C light chain of Fab fragment of 10B9 antibody 10090
423 4POZ 2 D heavy chain of Fab fragment of 10B9 antibody 10090
424 4F57 1 L Light chain of Fab of a neutralizing antibody L1 light chain of L1 9606
425 4F57 2 H Heavy chain of Fab of a neutralizing antibody L1 heavy chain of L1 9606
426 5MO3 2 H Fab of monoclonal antibody, heavy chain 10090
427 5MO3 3 L Fab of monoclonal antibody, light chain 10090
428 5GZ0 1 A, C FM329 light chain 1383439
429 5GZ0 2 B, D FM329 heavy chain 1383439
430 6DW2 1 A 6078 Fab light chain 9606
431 6DW2 2 B 6078 Fab heavy chain 9606
432 6MG4 1 A, B JTO light chain 9606
433 6BQB 1 L MGG4 Fab light chain 9606
434 6BQB 2 H MGG4 Fab heavy chain 9606
435 4PUB 1 H DX-2930 HEAVY CHAIN 9606
436 4PUB 2 L DX-2930 LIGHT CHAIN 9606
437 6B14 1 H Heavy chain of Fab BL3-6S97N 10090
438 6B14 2 L Light chain of Fab BL3-6S97N 10090
439 5DD6 1 A, H ANTI-HIV ANTIBODY DH570.mut58 FAB HEAVY CHAIN 9544
440 5DD6 2 B, L ANTI-HIV ANTIBODY DH570.mut58 FAB LIGHT CHAIN 9544
441 3WIH 2 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
442 3WIH 3 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
443 5GS3 1 A, H diabody protein 9606
444 3CFC 1 H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
445 3CFC 2 L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
446 3V4U 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
447 3V4U 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
448 5VKD 2 H Fab Heavy Chain 9606
449 5VKD 3 L Fab light chain 9606
450 2R1Y 1 A Fab, antibody fragment (IgG1k), light chain 10090
451 2R1Y 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
452 5XHG 1 A, C polypeptide(L) 10090
453 5XHG 2 B, D polypeptide(H) 10090
454 4XMP 2 H HEAVY CHAIN OF ANTIBODY VRC08 9606
455 4XMP 3 L LIGHT CHAIN OF ANTIBODY VRC08 9606
456 3UYR 1 H antibody Fab heavy chain 10090
457 3UYR 2 L antibody Fab light chain 10090
458 3V0W 1 L WN1 222-5 Fab (IgG2a) light chain 10090
459 3V0W 2 H WN1 222-5 Fab (IgG2a) heavy chain 10090
460 5OCX 1 L Fab fragment anti-citrullinated protein antibody E4 - light chain N-terminal glutamine is posttranslationally modified to pyroglutamic acid produced as chimera of human E4 mAb variable domains and mouse IgG2a constant domains 9606
461 5OCX 2 H Fab fragment of anti-citrullinated protein antibody E4 - heavy chain unmodelled residues not visible in electron density produced as chimera of human mAb E4 variable domains and mouse IgG2a constant domains 9606
462 1YQV 1 L HyHEL-5 Antibody Light Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
463 1YQV 2 H HyHEL-5 Antibody Heavy Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
464 3OAZ 1 H, M Fab 2G12, heavy chain Fab 9606
465 3OAZ 2 K, L Fab 2G12, light chain 9606
466 2R2B 1 A Fab, antibody fragment (IgG1k), light chain 10090
467 2R2B 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
468 1ZAN 1 L Fab AD11 Light Chain 10116
469 1ZAN 2 H Fab AD11 Heavy Chain 10116
470 6CJK 1 A, C Immunoglobulin Fab light chain 9986
471 6CJK 2 B, D Immunoglobulin Fab heavy chain 9986
472 4N0Y 1 H IGH526 Heavy Chain 9606
473 4N0Y 2 L IGH526 Light Chain 9606
474 3V52 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
475 3V52 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
476 6OTC 2 H sFab H3 heavy chain 32630
477 6OTC 3 L sFab H3 light chain 32630
478 5MTH 1 A, H antibody Fab heavy chain 10090
479 5MTH 2 B, L antibody Fab light chain 10090
480 3GGW 1 A, C FAB F22-4 LIGHT CHAIN 10090
481 3GGW 2 B, D FAB F22-4 HEAVY CHAIN 10090
482 1RZF 1 L Fab E51 light chain 9606
483 1RZF 2 H Fab E51 heavy chain 9606
484 5ZMJ 1 H Heavy chain of a Fab fraction of human IgG P01857 (UniProt) is referred. 9606
485 5ZMJ 2 L Light chain of a Fab fraction of human IgG P0DOY2(UniProt) is referred. 9606
486 6MY5 1 A, H anti-VEGF-A Fab fragment bH1 heavy chain 9606
487 6MY5 2 B, L anti-VEGF-A Fab fragment bH1 light chain 9606
488 4KTE 1 H GE148 Heavy Chain Fab Fab fragment 9544
489 4KTE 2 L GE148 Light Chain Fab 9544
490 5I8O 1 H HMM5 antibody heavy chain 9606
491 5I8O 2 L HMM5 antibody light chain 9606
492 4OUO 1 A anti Bla g 1 scFv 9031
493 4JG0 1 L Fab light chain 9606
494 4JG0 2 H Fab heavy chain 9606
495 4YGV 1 A, F aDabi-Fab2a heavy chain 9606
496 4YGV 2 B, L aDabi-Fab2a light chain 9606
497 5U4R 1 A, H VRC 315 53-1A09 Fab Heavy chain 9606
498 5U4R 2 B, L VRC 315 53-1A09 Fab Light chain 9606
499 5ALC 1 H ANTI-TICAGRELOR FAB 72, HEAVY CHAIN 9606
500 5ALC 2 L ANTI-TICAGRELOR FAB 72, LIGHT CHAIN 9606
501 5U5F 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
502 5U5F 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
503 3EO0 1 A, C GC-1008 Fab Light Chain 10090
504 3EO0 2 B, D GC-1008 Fab Heavy Chain 10090
505 5CIL 1 H FAB 4E10 HEAVY CHAIN 9606
506 5CIL 2 L FAB 4E10 LIGHT CHAIN 9606
507 6BI2 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
508 6BI2 2 L, M Trastuzumab Anti-HER2 Fab Light Chain 9606
509 5F3B 1 A, E RK35 Chimeric antibody heavy chain 10090
510 5F3B 2 B, F RK35 Chimeric antibody light chain 10090
511 4FQI 3 H antibody CR9114 heavy chain Fab 9606
512 4FQI 4 L antibody CR9114 light chain Fab Lambda 9606
513 6S5A 2 H anti P329G LALA Fab heavy chain 10090
514 6S5A 3 L anti P329G LALA Fab light chain 10090
515 4JHA 1 H D25 antigen-binding fragment heavy chain 9606
516 4JHA 2 L D25 light chain 9606
517 6B9Z 1 A Trastuzumab Fab light chain 10090
518 6B9Z 2 B Trastuzumab Fab heavy chain CSO is partially oxidized cysteine 10090
519 3MCL 1 L C706 MONOCLONAL LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
520 3MCL 2 H C706 MONOCLONAL HEAVY CHAIN FD fragment of the heavy chain, CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
521 4PTT 1 A Antibody pn132p2C05, light chain 9606
522 4PTT 2 B Antibody pn132p2C05, heavy chain 9606
523 5OD0 1 L Fab fragment of ACPA E4 - Light chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid 2 C-terminal residues not visible in electron density and therefore not modelled 9606
524 5OD0 2 H Fab fragment of ACPA E4 - heavy chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid residues not modeled are not visible in the electron density map 9606
525 5KVL 1 H Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) heavy chain Fab fragment 9606
526 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
527 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
528 5TDO 2 B, D anti-HER2 Fab Heavy Chain 9606
529 8FAB 1 A, C IGG1-LAMBDA HIL FAB (LIGHT CHAIN) 9606
530 8FAB 2 B, D IGG1-LAMBDA HIL FAB (HEAVY CHAIN) 9606
531 5NHW 1 H anti-human ActRII Bimagrumab Fab heavy-chain C-terminal FLAG-His6 tag Fab heavy-chain 9606
532 5NHW 2 L anti-human ActRII Bimagrumab Fab light-chain Fab light-chain 9606
533 2ZPK 1 L, M IgG1-lambda P20.1 Fab (light chain) 10090
534 2ZPK 2 H, I IgG1-lambda P20.1 Fab (heavy chain) Variable and Constant region 10090
535 4DGV 1 H HCV1 Heavy Chain Fab 9606
536 4DGV 2 L HCV1 Light Chain 9606
537 6C5K 1 A, H IgG1 Fab Heavy Chain 10090
538 6C5K 2 B, L IgG1 Fab Light Chain (Kappa) 10090
539 2DQU 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
540 2DQU 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
541 5TH2 1 A, C cetuximab Fab, light chain 10090
542 5TH2 2 B, D cetuximab Fab, heavy chain 10090
543 5I8K 1 L HHH1 Fab Light chain 9606
544 5I8K 2 H HHH1 Fab Heavy chain 9606
545 4YDL 2 B, H HEAVY CHAIN OF ANTIBODY C38-VRC18.02 9606
546 4YDL 3 C, L LIGHT CHAIN OF ANTIBODY C38-VRC18.02 9606
547 3T4Y 1 A S25-2 FAB (IGG1K) LIGHT CHAIN 10090
548 3T4Y 2 B S25-2 FAB (IGG1K) HEAVY CHAIN 10090
549 1YNL 1 L Ig gamma light chain 10090
550 1YNL 2 H Ig gamma heavy chain 10090
551 5EPM 1 A, E Antibody Fab fragment heavy chain 10090
552 5EPM 2 B, F Antibody Fab fragment light chain 10090
553 2AJS 1 L Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 kappa light chain 10090
554 2AJS 2 H Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
555 3UMT 1 A scFv heavy chain and light chain 10090
556 6U8D 2 H Heavy chain of Fab HCV2 Heavy chain of Fab HCV2 9606
557 6U8D 3 L Light chain of Fab HCV2 Light chain of Fab HCV2 9606
558 3BZ4 1 A, C, E, G Fab F22-4 light chain 10090
559 3BZ4 2 B, D, F, H Fab F22-4 heavy chain 10090
560 4NUJ 1 A PGT152 light chain 9606
561 4NUJ 2 B PGT152 heavy chain 9606
562 3LIZ 2 L 4C3 monoclonal antibody Light Chain 10090
563 3LIZ 3 H 4C3 monoclonal antibody Heavy Chain 10090
564 1RUA 1 L immunoglobulin igg2a, light chain fab 10090
565 1RUA 2 H immunoglobulin igg2a, heavy chain fab 10090
566 3U2S 1 A, H PG9 heavy chain antigen-binding fragment 9606
567 3U2S 2 B, L PG9 light chain 9606
568 6PE7 1 H FAB Heavy Chain 9606
569 6PE7 2 L FAB Light chain 9606
570 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
571 5D6C 2 B, H 4497 antibody IgG1 (VH and CH1) 9606
572 4GAG 1 H NEUTRALIZING ANTIBODY AP33 HEAVY CHAIN 10090
573 4GAG 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090
574 2R23 1 A Fab, antibody fragment (IgG1k), light chain 10090
575 2R23 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
576 4NUG 1 L PGT151 light chain 9606
577 4NUG 2 H PGT151 heavy chain 9606
578 3IU4 1 H chP3 Fab heavy chain 10090
579 3IU4 2 L chP3 Fab light chain 10090
580 3MNZ 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN mouse Fv,human Fc 10090
581 3MNZ 3 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN mouse Fv,human Fc 10090
582 6DC8 1 L IgG light chain 10090
583 6DC8 2 H IgG heavy chain 10090
584 3MLR 1 L Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab light chain 9606
585 3MLR 2 H Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab heavy chain 9606
586 1QYG 1 L FAB M82G2, LIGHT CHAIN 10090
587 1QYG 2 H FAB M82G2, HEAVY CHAIN 10090
588 6IAS 1 H Fab NKp46-1 heavy chain 32630
589 6IAS 2 L Fab NKp46-1 light chain 32630
590 1P7K 1 A, L antibody light chain FAB 10090
591 1P7K 2 B, H antibody heavy chain FAB 10090
592 6OBZ 1 A, H Heavy chain of FluA-20 Fab 9606
593 6OBZ 2 B, L Light chain of FluA-20 Fab, Immunoglobulin light chain 9606
594 3RVV 2 C 4C1 - light chain 10090
595 3RVV 3 D 4C1 - heavy chain 10090
596 5A2L 1 H SCFV-SM3 RESIDUES 6-115,20-129 10090
597 6GFE 2 L, M Immunoglobulin gamma-4 light chain 9606
598 3P0Y 2 H Fab DL11 heavy chain 9606
599 3P0Y 3 L Fab DL11 light chain 9606
600 4NPY 1 A, L germline PGT121 light chain Fab 9606
601 4NPY 2 B, H germline PGT121 heavy chain Fab 9606
602 6ANA 2 H LL2 Fab Heavy Chain 10090
603 6ANA 3 L LL2 Fab Light Chain 10090
604 5IBU 1 B, L 6652 Light Chain 9606
605 5IBU 2 G, H 6652 Heavy Chain 9606
606 5VPL 2 C 4C1 - LIGHT CHAIN 10090
607 5VPL 3 D 4C1 - HEAVY CHAIN 10090
608 6AOD 1 A FXIa Antibody FAB Light Chain 9606
609 6AOD 2 B FXIa Antibody FAB Heavy Chain 9606
610 5WCD 1 H VRC315 04-1D02 Fab Heavy chain 9606
611 5WCD 2 L VRC315 04-1D02 Fab Light chain 9606
612 2YPV 2 H FAB 12C1 10090
613 2YPV 3 L FAB 12C1 10090
614 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606
615 4HH9 2 B, D Fab KE5, heavy chain KE5 Heavy Chain 9606
616 4JY5 1 L PGT122 light chain Fab 9606
617 4JY5 2 H PGT122 heavy chain Fab 9606
618 6ELE 1 A, H fAB heavy chain 9606
619 6ELE 2 B, L fAB light chain 9606
620 5UR8 1 A human immunoglobulin gamma, heavy chain Fd fragment 9606
621 5UR8 2 B human immunoglobulin gamma, kappa light chain 9606
622 6B5R 1 H CIS42 Fab Heavy chain 9606
623 6B5R 2 L CIS42 Fab Light chain 9606
624 3NAC 1 L Fab15 Mut7 light chain 9606
625 3NAC 2 H Fab15 Mut7 heavy chain 9606
626 5U5M 1 A MEMAB TRASTUZUMAB, LIGHT CHAIN 9606
627 5U5M 2 B MEMAB TRASTUZUMAB, HEAVY CHAIN 9606
628 2DQT 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
629 2DQT 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
630 1Q72 1 L Fab M82G2, Light chain 10090
631 1Q72 2 H Fab M82G2, Heavy chain 10090
632 4M1D 1 L, M Fab mAb 447-52D Light Chain 9606
633 4M1D 2 H, I Fab mAb 447-52D Heavy Chain 9606
634 6MNQ 2 H Ab DH727.2 heavy chain Fab fragment 9544
635 6MNQ 3 L Ab DH727.2 light chain 9544
636 1SEQ 1 L Monoclonal Antibody MNAC13 FAB Light Chain 10090
637 1SEQ 2 H Monoclonal Antibody MNAC13 FAB Heavy Chain 10090
638 4YHO 1 H aDabi-Fab3 heavy chain 9606
639 4YHO 2 L aDabi-Fab3 light chain 9606
640 6FZR 1 H scFv-SM3 Special processing instructions: Although this structure is a ScFv, please follow the same numbering as shown in PDB entry 5OWP. 10090
641 6NMT 1 A Fab 3 anti-SIRP-alpha antibody Variable Light Chain 9606
642 6NMT 2 B Fab 3 anti-SIRP-alpha antibody Variable Heavy Chain 9606
643 2R1W 1 A Fab, antibody fragment (IgG1k), light chain 10090
644 2R1W 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
645 3MO1 1 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
646 3MO1 2 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
647 4DGY 1 H HCV1 Heavy Chain Fab 9606
648 4DGY 2 L HCV1 Light Chain 9606
649 5EN2 1 A GD01 heavy chain 10090
650 5EN2 2 B GD01 light chain 10090
651 3T77 1 A S25-2 FAB (IGG1K) light chain 10090
652 3T77 2 B S25-2 FAB (IGG1K) heavy chain 10090
653 6P4Y 1 H 4A10 Fab heavy chain 10090
654 6P4Y 2 L 4A10 Fab light chain 10090
655 3MXW 2 L 5E1 light chain 9606
656 3MXW 3 H 5E1 heavy chain 9606
657 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630
658 2V7N 2 B, D, F, H IMMUNOGLOBULIN HEAVY CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-259 32630
659 3EO9 1 L Efalizumab Fab fragment, light chain 9606
660 3EO9 2 H Efalizumab Fab fragment, heavy chain 9606
661 4ALA 2 H FAB 2H12 HEAVY CHAIN 10090
662 4ALA 3 L FAB 2H12 LIGHT CHAIN 10090
663 6N35 1 K, L Fab 2G12 light chain 9606
664 6N35 2 H, M Fab 2G12 heavy chain 9606
665 4F33 1 A, C, E, G MORAb-009 FAB light chain 10090
666 4F33 2 B, D, F, H MORAb-009 FAB heavy chain 10090
667 3C6S 1 A, C, E, G Fab F22-4 light chain 10090
668 3C6S 2 B, D, F, H Fab F22-4 heavy chain 10090
669 5WUV 1 L light chain 9606
670 5WUV 2 H heavy chain 9606
671 4Z8F 1 H S1-15 Fab (IgG2b) heavy chain 10090
672 4Z8F 2 L S1-15 Fab (IgG2b kappa) light chain 10090
673 3OKL 1 A S25-39 Fab (IgG1k) light chain 10090
674 3OKL 2 B S25-39 Fab (IgG1k) heavy chain 10090
675 4JM4 1 H PGT 135 Heavy Chain Fab 9606
676 4JM4 2 L PGT 135 Light Chain Fab 9606
677 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
678 2HWZ 2 H Immunoglobulin Fab heavy chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
679 5YE4 1 A, C 1A9D7 VH CH1 chain 10090
680 5YE4 2 B, D 1A9D7 L chain 10090
681 6B0G 1 C 1245 Antibody, Light Chain 9606
682 6B0G 2 D 1245 Antibody, Heavy Chain 9606
683 5TDP 1 A, C anti-HER2 Fab Light Chain 9606
684 5TDP 2 B, D anti-HER2 Fab Heavy Chain 9606
685 1ZEA 1 L monoclonal anti-cholera toxin IGG1 KAPPA antibody, L chain 10090
686 1ZEA 2 H monoclonal anti-cholera toxin IGG1 KAPPA antibody, H chain 10090
687 6BAH 1 A Trastuzumab Fab light chain,Immunoglobulin kappa constant 10090
688 6BAH 2 B Trastuzumab Fab heavy chain,IGH@ protein 10090
689 6D0X 1 A 2140 Antibody, heavy chain 9606
690 6D0X 2 B 1210 Antibody, light chain 9606
691 6BE4 1 H Fab (F598) Heavy Chain 9606
692 6BE4 2 L Fab(F598) Light Chain 9606
693 5TPP 1 L DH270.5 Fab heavy chain 9606
694 5TPP 2 H DH270.5 Fab light chain 9606
695 5L88 1 H Anti-afamin antibody N14, Fab fragment, heavy chain 10090
696 5L88 2 L Anti-afamin antibody N14, Fab fragment, light chain 10090
697 1Q9W 1 A, C S45-18 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
698 1Q9W 2 B, D S45-18 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090
699 4P3C 1 H Heavy Chain Fab fragment of antibody LEM-2/15 MT1-MMP V-B loop 10090
700 4P3C 2 L Light Chain Fab fragment of antibody LEM-2/15 10090
701 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606
702 1L7I 2 H chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence heavy chain (residues 1-216) 9606
703 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606
704 1JPT 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606
705 1AQK 1 L FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
706 1AQK 2 H FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
707 5TL5 1 L M2177 LIGHT CHAIN 10090
708 5TL5 2 H M2177 HEAVY CHAIN 10090
709 2FX7 1 L Fab 4E10 Light Chain 9606
710 2FX7 2 H Fab 4E10 Heavy Chain 9606
711 6O39 1 A Antibody F2.I Fab, Light chain 9606
712 6O39 2 B Antibody F2.I Fab, Heavy chain 9606
713 5Y9K 1 L belimumab light chain 9606
714 5Y9K 2 H belimumab heavy chain 9606
715 4DTG 1 L Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, light chain 9606
716 4DTG 2 H Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, heavy chain 9606
717 5CSZ 1 A, H GANTENERUMAB FAB FRAGMENT HEAVY CHAIN FAB 9606
718 5CSZ 2 B, L GANTENERUMAB FAB FRAGMENT LIGHT CHAIN FAB 9606
719 6GLW 2 C, H Fab 1D11 - Heavy chain 9844
720 6GLW 3 D, L Fab 1D11 - Light chain 9844
721 3WFH 1 A mAb Fab H fragment 10090
722 3WFH 2 B mAb Fab L fragment 10090
723 4K3D 1 H, I BOVINE ANTIBODY WITH ULTRALONG CDR H3, HEAVY CHAIN 9913
724 4K3D 2 L, M BOVINE ANTIBODY WITH ULTRALONG CDR H3, LIGHT CHAIN 9913
725 4H8W 2 H FAB HEAVY CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
726 4H8W 3 L FAB LIGHT CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
727 3HNT 1 H CS-35 Fab Heavy Chain Heavy Chain 10090
728 3HNT 2 L CS-35 Fab Light Chain Light Chain 10090
729 6GKU 2 H Fab 6F5 - Heavy Chain 9844
730 6GKU 3 L Fab 6F5 - Light chain 9844
731 1WEJ 1 L E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
732 1WEJ 2 H E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
733 5VPG 2 C FAB 4C1 - LIGHT CHAIN 10090
734 5VPG 3 D FAB 4C1 - HEAVY CHAIN 10090
735 5HI4 2 C, H CAT-2000 FAB heavy chain 9606
736 5HI4 3 D, L CAT-2000 FAB light chain 9606
737 5NUZ 1 A, H eOD01 heavy chain Fab fragment (domains: variable heavy and constant heavy 1) Fab fragment (domains: variable heavy and constant heavy 1) 10090
738 5NUZ 2 B, L eOD01 light chain Fab fragment (domains: variable light and constant light) Fab fragment (domains: variable light and constant light) 10090
739 6QKD 1 H, I, J, K FAB HEAVY CHAIN 9844
740 6QKD 2 L, M, O, T FAB LIGHT CHAIN 9844
741 5FCU 2 H JR4 FAB HEAVY CHAIN 9544
742 5FCU 3 L JR4 FAB LIGHT CHAIN 9544
743 3RVW 2 C 4C1 - light chain 10090
744 3RVW 3 D 4C1 - heavy chain 10090
745 5DD3 1 H ANTI-HIV ANTIBODY DH570.4 FAB HEAVY CHAIN 9544
746 5DD3 2 L ANTI-HIV ANTIBODY DH570.4 FAB LIGHT CHAIN 9544
747 5XKU 2 B HNIgGA6 light chain 9606
748 5XKU 3 C HNIgGA6 heavy chain 9606
749 3D85 1 A FAB of antibody 7G10, light chain light chain 9606
750 3D85 2 B FAB of antibody 7G10, heavy chain heavy chain 9606
751 4Z95 1 H S1-15 Fab (IgG2b) heavy chain 10090
752 4Z95 2 L S1-15 Fab (IgG2b) light chain 10090
753 5HI5 2 C, H CAT-2000 FAB heavy chain 9606
754 5HI5 3 D, L CAT-2000 light chain 9606
755 5JO5 1 A, C, E, H 10E8 gHV 9606
756 5JO5 2 B, D, F, L 10E8 gLV 9606
757 5L9D 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN 10090
758 5L9D 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN 10090
759 5CCK 1 H Antibody 3BC315 Fab heavy chain 9606
760 5CCK 2 L Antibody 3BC315 Fab light chain 9606
761 6RNN 1 C, L Immunoglobulin light chain 10090
762 6GXX 1 H FAB 1D9 heavy chain 10090
763 6GXX 2 L FAB 1D9 light chain 10090
764 5I76 1 A, C FM318_light_chain 1383439
765 5I76 2 B, D FM318_heavy_cahin 1383439
766 1KCV 1 L PC282 IMMUNOGLOBULIN light chain 10090
767 1KCV 2 H PC282 IMMUNOGLOBULIN heavy chain 10090
768 1FLR 1 L 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
769 1FLR 2 H 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
770 6MTT 1 L Antibody VRC46.01 Fb light chain 9606
771 6MTT 2 H Antibody VRC46.01 Fab heavy chain 9606
772 5I18 1 L FAB LIGHT CHAIN 9606
773 5I18 2 H FAB HEAVY CHAIN 9606
774 6QB3 2 X scFv55 9606
775 4JN1 1 H anti-dabigatran Fab1, heavy chain 10090
776 4JN1 2 L anti-dabigatran Fab1, light chain 10090
777 6UGS 1 A, H Infliximab (Remicade) Fab Heavy Chain 9606
778 6UGS 2 B, L Infliximab (Remicade) Fab Light Chain 9606
779 4P3D 1 A, H Heavy Chain Fab fragment of antibody LEM-2/15 10090
780 4P3D 2 B, L Light Chain Fab fragment of antibody LEM-2/15 10090
781 4G5Z 1 H canakinumab antibody fragment heavy chain 9606
782 4G5Z 2 L canakinumab antibody fragment light chain 9606
783 6HKG 1 A FISW84 Fab Fragment Heavy Chain 9606
784 6HKG 2 B FISW84 Fab Fragment Light Chain 9606
785 6HKG 3 C FISW84 Fab Fragment Heavy Chain 9606
786 3TNM 1 A, H Fab heavy chain of human anti-HIV-1 Env antibody A32 9606
787 3TNM 2 B, L Fab light chain of human anti-HIV-1 Env antibody A32 9606
788 2OK0 2 L Fab ED10 light chain 10090
789 2OK0 3 H Fab ED10 heavy chain 10090
790 3SOB 1 L antibody light chain 9606
791 3SOB 3 H antibody heavy chain 9606
792 6B5M 1 H CIS43 Fab Heavy chain 9606
793 6B5M 2 L CIS43 Fab Light chain 9606
794 5AWN 1 H Heavy chain of 3BC176 Fab 9606
795 5AWN 2 L Light chain of 3BC176 Fab 9606
796 4ZFO 2 L J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
797 4ZFO 3 A, H J22.9-xi Fab, Heavy Chain Fab Heavy Chain fragment of anti-BCMA antibody J22.9-xi 10090
798 4ZFO 4 B J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
799 4G6M 2 H heavy chain of gevokizumab antibody binding fragment 10090
800 4G6M 3 L light chain of gevokizumab antibody binding fragment 10090
801 5DR5 1 H AbD09097 Fab heavy chain The Fab heavy chain contains a C-terminal Myc- and hexahistidine extension preceded by thrombin peptidase recognition sequence to facilitate detection and purification 9606
802 5DR5 2 L AbD09097 Fab light chain 9606
803 6MG5 1 A, B Light chain JTO 9606
804 2IH3 1 A FAB Heavy Chain 10090
805 2IH3 2 B FAB Light Chain 10090
806 4KQ3 1 L CNTO3186 light chain Fab 9606
807 4KQ3 2 H CNTO3186 heavy chain Fab 9606
808 6AQ7 2 H POM6 FAB Heavy CHAIN 10090
809 6AQ7 3 L POM6 FAB light CHAIN 10090
810 4JFX 1 A, L Fab light chain 9606
811 4JFX 2 B, H Fab heavy chain 9606
812 3SGE 1 I, L Light Chain 10090
813 3SGE 2 H, J Heavy Chain 10090
814 1BM3 1 L IMMUNOGLOBULIN OPG2 FAB, CONSTANT DOMAIN CONSTANT DOMAIN 10090
815 1BM3 2 H IMMUNOGLOBULIN OPG2 FAB, VARIABLE DOMAIN VARIABLE DOMAIN 10090
816 4TUJ 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
817 4TUJ 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
818 2VXQ 2 H FAB H CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
819 2VXQ 3 L FAB L CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
820 2XWT 1 A THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 HEAVY CHAIN FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-229 9606
821 2XWT 2 B THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 LIGHT CHAIN FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-213 9606
822 5FHB 1 H Antibody 100 Fab heavy chain 9606
823 5FHB 2 L Antibody 100 Fab light chain 9606
824 3HZM 1 A S73-2 Fab (IgG1k) light chain 10090
825 3HZM 2 B S73-2 Fab (IgG1k) heavy chain 10090
826 1JGU 1 L Antibody Light Chain 10090
827 1JGU 2 H Antibody Heavy Chain 10090
828 4I77 1 H Lebrikizumab heavy chain Fab 9606
829 4I77 2 L Lebrikizumab light chain Fab 9606
830 4OCR 1 L CAP256-VRC26.01 light chain Fab 9606
831 4OCR 2 H CAP256-VRC26.01 heavy chain Fab 9606
832 4O4Y 1 L 2095-2 light chain SEE REMARK 999 9986
833 4O4Y 2 H 2095-2 heavy chain 9986
834 5OBF 1 H fAb Heavy chain 10090
835 5OBF 2 L fAb Light chain 10090
836 6QNK 1 A, C FAB light chain 10090
837 6QNK 2 B, D FAB heavy chain 10090
838 5LGH 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN IGG1-KAPPA HEAVY CHAIN, 1-214 10090
839 5LGH 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN IGG1-KAPPA LIGHT CHAIN, 1-214 10090
840 1UZ8 1 A, L IGG FAB (IGG3, KAPPA) LIGHT CHAIN 291-2G3-A FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-212 10090
841 1UZ8 2 B, H IGG FAB (IGG3, KAPPA) HEAVY CHAIN 291-2G3-A FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-213 10090
842 1DQQ 1 A, C ANTI-LYSOZYME ANTIBODY HYHEL-63 (LIGHT CHAIN) FAB FRAGMENT 10090
843 1DQQ 2 B, D ANTI-LYSOZYME ANTIBODY HYHEL-63 (HEAVY CHAIN) FAB FRAGMENT 10090
844 5L7X 1 H Mouse Antibody Fab Fragment, IgG1-kappa Heavy Chain IgG1-kappa heavy chain, 1-214 10090
845 5L7X 2 L Mouse Antibody Fab Fragment, IgG1-kappa Light Chain IgG1-kappa light chain, 1-214 10090
846 5V6M 1 L Light chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
847 5V6M 2 H Heavy chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
848 5MHE 1 L Fab-fragment 10090
849 5MHE 2 H Fab-fragment 10090
850 5YFI 1 L Light chain of Fab fragment 10090
851 5YFI 2 H Heavy chain of Fab fragment 10090
852 4GLR 2 H, J anti-ptau heavy chain heavy chain 9031
853 4GLR 3 I, K anti-ptau light chain light chain 9031
854 5WK3 1 P, R, T, V M116 LIGHT CHAIN 9606
855 5WK3 2 Q, S, U, W M116 HEAVY CHAIN FD 9606
856 6MTR 1 H Antibody VRC43.01 Fab heavy chain 9606
857 6MTR 2 L Antibody VRC43.01 Fab light chain 9606
858 4HJG 1 A Trastuzumab light chain 9606
859 4HJG 2 B Trastuzumab heavy chain 9606
860 5OWP 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region H2020 10090
861 4M43 1 L Fragment antigen-binding 523-11 light chain 10090
862 4M43 2 H Fragment antigen-binding 523-11 heavy chain 10090
863 5I30 1 L Fab PL-2 light chain 10090
864 5I30 2 H Fab PL-2 heavy chain 10090
865 3HC0 1 A, H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
866 3HC0 2 B, L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
867 3BKC 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
868 3BKC 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
869 6CT7 1 B, L BIIB054 Fab light chain 9606
870 6CT7 2 A, H BIIB054 Fab heavy chain 9606
871 3FN0 1 L Fab Z13e1 light chain 9606
872 3FN0 2 H Fab Z13e1 heavy chain 9606
873 5X5X 1 H Fd chain of anti-osteocalcin antibody KTM219 10090
874 5X5X 2 L L chain of anti-osteocalcin antibody KTM219 10090
875 4YHI 1 A, H aDabi-Fab2a heavy chain 9606
876 4YHI 2 B, L aDabi-Fab2a light chain 9606
877 5NYX 1 H, M, O HEAVY CHAIN CHAIN H AND O ARE TWO SEPARATE POLYPEPTIDE CHAINS. fab heavy chains. The sequence provided contains the cleavable strep tag that has been removed prior to crystallisation 9606
878 5NYX 2 L, N, P LIGHT CHAIN fab light chain 9606
879 5YUP 1 H the heavy chain of the Fab fragment of FVIIa antibody mAb4F5 10090
880 5YUP 2 L the light chain of the Fab fragment of FVIIa antibody mAb4F5 10090
881 4OSU 1 H SM5-1 Fab Heavy Chain 9606
882 4OSU 2 L SM5-1 Fab Light Chain 9606
883 3MXV 1 L fab fragment of anti-Shh 5E1 mouse/human chimera, light chain 10090
884 3MXV 2 H fab fragment of anti-Shh 5E1 mouse/human chimera, heavy chain 10090
885 5IFA 1 H VRC01c-HuGL2 Fab heavy chain 9606
886 5IFA 2 L VRC01c-HuGL2 Fab light chain 9606
887 1T2Q 1 L Fab NNA7 Heavy Chain 10090
888 1T2Q 2 H Fab NNA7 Light Chain 10090
889 6ELJ 1 A, H fAB heavy chain 9606
890 6ELJ 2 B, L fAB light chain 9606
891 4G6K 1 H heavy chain of gevokizumab antibody binding fragment 10090
892 4G6K 2 L light chain of gevokizumab antibody binding fragment 10090
893 4MAU 1 L C2244 light chain SEE REMARK 999 10090
894 4MAU 2 H C2244 heavy chain FD, SEE REMARK 999 10090
895 3LEX 1 A, H 11f10 Antibody Heavy Chain 10090
896 3LEX 2 B, L 11f10 Antibody Light Chain 10090
897 6B0W 1 L 1710 antibody, light chain 9606
898 6B0W 2 H 1710 antibody, heavy chain 9606
899 6DC7 1 L, M Fab light chain 10090
900 6DC7 2 H, I Fab heavy chain 10090
901 5VH4 1 A, H Infliximab Fab Heavy Chain 10090
902 5VH4 2 B, L Infliximab Fab Light Chain 10090
903 6NOU 1 A scFv derived from ixekizumab 9606
904 5DQD 1 L S55-5 Fab (IgG1 kappa) light chain 10090
905 5DQD 2 H S55-5 Fab (IgG1) heavy chain 10090
906 5DT1 1 H Fab Heavy chain of broadly neutralizing antibody VRC26.25 9606
907 5DT1 2 L Fab Light chain of broadly neutralizing antibody VRC26.25 9606
908 4ONF 1 H 3D6 FAB ANTIBODY HEAVY CHAIN 10090
909 4ONF 2 L 3D6 FAB ANTIBODY LIGHT CHAIN 10090
910 1OPG 1 L OPG2 FAB (LIGHT CHAIN) 9606
911 1OPG 2 H OPG2 FAB (HEAVY CHAIN) 9606
912 1JPS 1 L immunoglobulin Fab D3H44, light chain Fab fragment 9606
913 1JPS 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606
914 5NPJ 1 A, B Single chain variable fragment of the non-neutralizing antibody DAO5 10090
915 1NBY 1 A antibody kappa light chain first chain of Anti-Lysozyme Antibody HyHEL-63 light chain 10090
916 1NBY 2 B immunoglobulin gamma 1 chain second chain of Anti-Lysozyme Antibody HyHEL-63 10090
917 3V6O 2 C, D Monoclonal antibody 9F8 fab fragment Heavy chain Fab fragment of monoclonal antibody H chain 10090
918 3V6O 3 E, F Monoclonal antibody 9F8 fab fragment Light chain Fab fragment of monoclonal antibody L chain 10090
919 3S96 1 A, C 3B5H10 FAB heavy chain 10090
920 3S96 2 B, D 3B5H10 FAB light chain 10090
921 6CBV 1 H Heavy chain, Fab fragment 9606
922 6CBV 2 L Light Chain, Fab fragment 9606
923 4LKX 1 A Fab fragment heavy chain 9606
924 4LKX 2 B Fab fragment light chain 9606
925 1Q9O 1 B, D S45-2 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090
926 1Q9O 2 A, C S45-2 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
927 6QB9 1 A, X scFv55 9606
928 3SE8 2 H Heavy chain of antibody VRC03 Antigen binding fragement of antibody heavy chain 9606
929 3SE8 3 L Light chain of antibody VRC03 antibody light chain 9606
930 5JW5 1 A, H MEDI8852 Heavy chain 9606
931 5JW5 2 B, L MEDI8852 Light chain 9606
932 5VH3 1 A, H Infliximab Fab Heavy Chain 10090
933 5VH3 2 B, L Infliximab Fab Light Chain 10090
934 6DCV 1 A, L Light chain of CBTAU27.1 Fab 9606
935 6DCV 2 B, H heavy chain of CBTAU-27.1 Fab 9606
936 5HDQ 2 H Fab Heavy Chain 10090
937 5HDQ 3 L Fab Light Chain 10090
938 4FQ2 1 H Fab heavy chain 9606
939 4FQ2 2 L Fab light chain 9606
940 3RKD 2 C, L Monoclonal Antibody, Light Chain 10090
941 3RKD 3 D, H Monoclonal Antibody, Heavy Chain 10090
942 3L1O 1 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 H CHAIN 10090